Medipharm Labs CorporationMedipharm Labs CorporationMedipharm Labs Corporation

Medipharm Labs Corporation

No trades
No trades

Compare with Medipharm Labs Corporation


Market capitalization
‪21.02 M‬ USD
−0.0083 USD
‪−6.02 M‬ USD
‪32.86 M‬ USD
‪386.55 M‬
Beta (1Y)
−0.07
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Employees (FY)
127
Change (1Y)
−34−21.12%
Revenue / Employee (1Y)
‪258.73 K‬ USD
Net income / Employee (1Y)
‪−47.40 K‬ USD

Company info


CEO
Greg Hunter
Headquarters
Barrie
Founded
2015
IPO date
Feb 9, 2018
ISIN
CA58504D1006
CUSIP
58504D100
FIGI
BBG00M61H441
Identifiers
ISIN CA58504D1006
CFI code
ESVUFR
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. It focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon and Keith Strachan in 2015 and is headquartered in Barrie, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of MEDIF is 0.0530 USD — it has increased by 0.19% in the past 24 hours. Watch Medipharm Labs Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Medipharm Labs Corporation stocks are traded under the ticker MEDIF.
MEDIF stock has risen by 23.83% compared to the previous week, the month change is a −3.64% fall, over the last year Medipharm Labs Corporation has showed a −0.56% decrease.
MEDIF reached its all-time high on May 22, 2019 with the price of 5.6500 USD, and its all-time low was 0.0374 USD and was reached on Aug 5, 2024. View more price dynamics on MEDIF chart.
See other stocks reaching their highest and lowest prices.
MEDIF stock is 12.77% volatile and has beta coefficient of −0.07. Track Medipharm Labs Corporation stock price on the chart and check out the list of the most volatile stocks — is Medipharm Labs Corporation there?
Today Medipharm Labs Corporation has the market capitalization of ‪21.02 M‬, it has decreased by −0.82% over the last week.
Yes, you can track Medipharm Labs Corporation financials in yearly and quarterly reports right on TradingView.
Medipharm Labs Corporation is going to release the next earnings report on Nov 16, 2026. Keep track of upcoming events with our Earnings Calendar.
Medipharm Labs Corporation revenue for the last quarter amounts to ‪7.03 M‬ USD, despite the estimated figure of ‪6.28 M‬ USD. In the next quarter, revenue is expected to reach ‪7.15 M‬ USD.
MEDIF net income for the last quarter is ‪2.82 K‬ USD, while the quarter before that showed ‪−623.30 K‬ USD of net income which accounts for 0.00% change. Track more Medipharm Labs Corporation financial stats to get the full picture.
No, MEDIF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 4, 2026, the company has 127 employees. See our rating of the largest employees — is Medipharm Labs Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Medipharm Labs Corporation EBITDA is ‪−2.41 M‬ USD, and current EBITDA margin is −15.48%. See more stats in Medipharm Labs Corporation financial statements.
Like other stocks, MEDIF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Medipharm Labs Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Medipharm Labs Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Medipharm Labs Corporation stock shows the sell signal. See more of Medipharm Labs Corporation technicals for a more comprehensive analysis.